HopeStage
Back to all studies
RecruitingNCT05359562

Hormonal cycle timing and exposure therapy for women with OCD

About this titleRead the official source — NCT05359562
Behavioural studyAges 18–45United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 45 years.

Listed locations
New York and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 15, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
University of Pennsylvania
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT05359562
Official title
Show the full official title

Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD

Recruitment & locations

Currently recruiting

New York · Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pennsylvania, a university.

Who can participate?

Listed age limits: 18 years to 45 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies